Is the Treg-engineered donor product Orca-T safe and effective at preventing aGvHD?

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the GvHD Hub spoke to Everett H. Meyer, Stanford University, Stanford, US. We asked, Is the Treg-engineered donor product Orca-T safe and effective at preventing acute graft-versus-host disease (GvHD)?

Meyer talks about the promising results of an ongoing phase II trial evaluating the safety and efficacy of Orca-T in preventing GvHD.